Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Demand for Obesity Drugs Has Insurers Paying Close Attention
Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
WeightWatchers Gets a Makeover With Obesity-Drug Business
Markets Heard on the Street The decision to get into the business for drugs such as Ozempic makes sense Source link
UnitedHealth First-Quarter Earnings, Revenue Up as Company Added Members
Business Earnings Company sees moderate health spending, but higher costs for drugs such as Ozempic Source link
National CineMedia Files for Bankruptcy as Latest Casualty of Cinema Slump
National CineMedia LLC, the largest movie-theater advertisement business in North America, filed for bankruptcy Tuesday after facing years of challenges from reduced attendance at cinemas
China Consumer Price Growth Eases, Reflecting Caution on the Economy
Economy Asia Economy While the scrapping of Covid controls has opened up the economy, joblessness and an uncertain outlook have kept a lid on domestic
Johnson & Johnson’s Talc Plan Spotlights Chapter 11 Voting Power
Johnson & Johnson’s latest plan to resolve mass cancer lawsuits through bankruptcy could force some cosmetic-talc users and their lawyers into a settlement they don’t
The Pandemic Didn’t End Card Rewards. It Made Them Stronger.
Americans love their credit card rewards more than ever. For card companies, perhaps too much. When the Covid-19 pandemic halted travel—and travel spending—some speculated that
The Pandemic Didn’t End Card Rewards. It Made Them Stronger.
Americans love their credit card rewards more than ever. For card companies, perhaps too much. When the Covid-19 pandemic halted travel—and travel spending—some speculated that
They Took This Drug to Fight Aging. But Does It Actually Work?
An antiaging crowd latched onto the diabetes drug metformin hoping it would extend lifespan. Studies give conflicting results. Source link